What is it?
Kava is an herbal medicine used for treating anxiety (feeling nervous) and stress.
Other names for Kava include: Piper methysticum, Ava, Intoxicating Pepper, Kao, Kava-Kava, and Kawa.
Ask your doctor, nurse, or pharmacist if you need more information about this medicine or if any information in this leaflet concerns you.
References:
1. Almeida JC & Grimsley EW: Coma from the health food store: interaction between kava and alprazolam (letter). Ann Intern Med 1996; 125:940-941.
2. Blumenthal M, Gruenwald J, Hall T et al: German Commission E Monographs. American Botanical Council, Austin, TX; 1998.
3. Brinker F: Herb Contraindications and Drug Interactions, 2nd ed. Eclectic Medical Publications, Sandy, OR; 1998.
4. Cawte J: Parameters of kava used as a challenge to alcohol. Aust N Z. J. Psychiatry 1986; 20:70-76.
5. Chavallier A: The Encyclopedia of Medicinal Plants. DK Publishing Company, New York, NY; 1996.
6. Escher M, Desmeules J, Giostra E et al: Hepatitis associated with kava, a herbal remedy for anxiety. BMJ 2001; 322(7279):139.
7. Fachinformation: Antares(R) 120, kava-kava extract. Krewel Meuselbach GmbH, Eitorf, Germany; 1996.
8. Fachinformation: Kavosporal(R) forte, kava-kava extract. Mueller Goeppingen Gmbh & Co KG, Goeppingen, Germany; 1996.
9. Gleitz J, Beile A & Wilkens P et al: Antithrombotic action of the Kava pyrone kavain prepared from Piper methysticum on Human Platelets. Planta Medica 1997;63:27-30.
10. Jamieson DD & Duffield PH: Interaction of kava and ethanol in mice. Eur J Pharmacol 1990; 183:559.
11. Jamieson DD & Duffield PH: Positive interaction of ethanol and kava resin in mice. Clin Exp Pharmacol Physiol 1990; 17:509-514.
12. Jussofie B, Schmiz A & Hiemke C: Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain. Psychopharmacol 1994; 116:469-474.
13. Kraft M, Spahn TW, Menzel J et al: Fulminant liver failure after administration of the herbal antidepressant kava-kava (Abstract). Dtsch Med Wochenschr 2001; 126(36):970-972.
14. Lewis-Taylor C: FDA Letter to Healthcare Professionals. Dec 19, 2001. Available at: http://www.fda.gov/medwatch/safety/2001/safety01.htm#kava (cited 12/20/2001).
15. Mathews JD, Riley MD, Fejo L et al: Effects of the heavy usage of kava on physical health: summary of a pilot survey in an Aboriginal community. Med J Aust 1988; 148:548-555.
16. Norton SA & Ruze P: Kava dermopathy. J Am Acad Dermatol 1994; 31:89-97.
17. Schelosky L, Raffauf C, Jendroska K et al: Kava and dopamine antagonism. J Neurol Neurosurg Psych 1995; 58:639-640.
18. Strahl S, Ehret V, Dahm HH et al: Necrotizing hepatitis after taking herbal remedies (abstract). Dtsch Med Wochenschr 1998; 123(47):1410-1414.
19. Uebelhack R, Franke L & Schewe JH: Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava). Pharmacopsychiatry 1998; 31:187-192.